One-third of healthcare administrative spending could be automated and save $13.3 billion, according to a report by CAQH.

Centene has passed all regulatory hurdles to seal the deal on a merger with WellCare Health Plans worth $17.3 billion.

Amazon is signaling it may soon sell prescription drugs in the U.K., Canada and Australia after the company moved to trademark “Amazon Pharmacy” in those countries at the start of 2020, CNBC reported.

More accountable care organizations are taking on downside financial risk in the Medicare Shared Savings Program than ever before, with 37% in the program today participating in these arrangements.

The Supreme Court won’t take up the ongoing appeal over the constitutionality of the Affordable Care Act, leaving the decision in the hands of a lower court.

The world could soon have a new most expensive drug if an experimental gene therapy for hemophilia patients could come in with a price tag between $2 million and $3 million is approved.

Sundar Pichai, who serves as the CEO for both Alphabet and Google, wants the United States and European Union to work together on developing AI regulations.

The Centers for Medicare & Medicaid Innovation savings projections keep moving, underscoring just how difficult it is to estimate the impact of untested alternative payment models, according to a recent analysis from Avalere Health.